• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Pathology & Laboratory Medicine

UCLA Pathology & Laboratory Medicine

UCLA Pathology & Laboratory Medicine
  • About Us
    • Chair's Message
    • Leadership
    • Administration / Contacts
    • Locations
    • Licensure & Accreditation
    • Path & Lab News
    • Wellness
    • Giving to Pathology
  • Clinical Services
    • Anatomic Pathology
    • Laboratory Medicine
    • Clinical Genomics Center
    • Immunogenetics Center
    • International Collaborations
    • Olympic Lab
    • Outreach
    • Center for Telepathology and Digital Pathology
    • Quality Improvement and Clinical Innovation
  • Education
    • Pathology Grand Rounds
    • Medical & Dental Education
    • Residency Program
    • Fellowship Programs
    • Research Training
    • Allied Health Training
  • Research Enterprise
    • Infrastructure
    • Collaboration
    • Research Faculty
    • Research Training
    • Funding Opportunities
    • Research Assistants/Associates
  • Research Services
    • Brain Tumor Translational Resource (BTTR)
    • Immunogenetics (UIC)
    • Immune Assessment Core (IAC)
    • Pathology Research Portal (PRP)
    • Translational Pathology Core Laboratory (TPCL)
    • Technology Center for Genomics & Bioinformatics (TCGB)
  • Quick Links
    • Business Office
    • Faculty/Staff Resources
    • Intranet
    • Locations
    • Path IT Service Now
    • Submit Website Changes
  • Meet Our Faculty
    • Primary
    • Affiliates
    • Joint Appointment
    • MSP
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Pathology & Laboratory Medicine

Immune Assessment Core (IAC)

Immune Assessment Core (IAC)

Immune Assessment Core (IAC)

  • Services and Pricing
    • Flow Cytometry Based Immune Assessment
    • Immunoassays
    • Real-Time Cell Lysis and Cell Proliferation
  • Resources
  • How to Use
  • Contact Us
  • Services and Pricing
  • Resources
  • How to Use
  • Contact Us
  • Flow Cytometry Based Immune Assessment
  • Immunoassays
  • Real-Time Cell Lysis and Cell Proliferation
  1. Home
  2. Research Services
  3. Immune Assessment Core (IAC)
  4. Services and Pricing
  5. Real-Time Cell Lysis and Cell Proliferation

Real-Time Cell Lysis and Cell Proliferation

Services Provided

The ACEA xCELLigenceTM Technology uses a microelectronic biosensor system to monitor cellular events in real time without the incorporation of labels. The instruments measure electrical impedance across interdigitated micro-electrodes integrated on the bottom of its special tissue culture plates. xCELLigence comprises a measurement unit housed within a standard tissue culture incubator. It continuously monitors electrical impedance over the entire time period (30 minutes to 72 hours) of the experiment to obtain dynamic real-time data. The real-time impedance measurement improves on conventional endpoint assays and provides quantitative information about the biological status of the cells, including cell number, adhesion, viability, and morphology. xCELLigence has wide applications, most notably in the measurement of drug or cell mediated cytotoxicity, virus-mediated cytopathogenicity, cell proliferation, cell adhesion and migration. The IAC is equipped with the xCELLigence RTCA MP System and the xCELLigence RTCA DP System. Visit the ACEA™ website for a complete list of xCelligence applications. 

Using xCELLigence system, we currently offer two assay types: tumor specific cytotoxic T lymphocyte or NK cell killing assays, which provide up to four times the sensitivity of traditional dye-release methods; and stimulus-induced cell proliferation and proliferation inhibition assays, which measure real-time cell killing, cell proliferation, and morphological changes of adherent cells with high sensitivity. An example is provided below (Figure 1). Researchers are welcomed to set up their custom assays in our tissue culture facility and run the plates on our instruments.

real time cell

Figure 1.  Cytotoxicity to cancer cells by cytotoxic T lymphocyte (CTL). xCELLigence real time impedance plots at various effector target ratio (E:T 0:1). Negative control: cancer cells only. Positive control: cancer cells lysed with 1% triton x-100.

Experiment design: 16-well CIM plates and 16-well E-plates are used for the DP system; 96-well E-plates are used for the MP system.  It is recommended to run samples in multiple replicates. The latter, for example, is capable of testing 30 experimental conditions in triplicate (not including negative and positive controls). Proper negative and positive controls should be included in each run. The E-plates are not intended for multiple uses.

Facebook Twitter Instagram Youtube LinkedIn
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap